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Caldumlcalmodulin dependent protein kinase II (CaM kinase II) seems to act as an important regulator of intracellular signal transmission. Four 
subtypes, termed IX to 6, have been cloned; some of them can exist as different splicing variants. All these isoforms share a great overall homology, 
and they contain 3 areas of low homology. We have identified 5 new variants of subtype delta so that the total number of different isoforms now 
adds up to 12. These variants are probably a result of different splicing and show several deletions in regard to subtype delta. The deletion sites 
do exactly match regions of low homology between the subtypes. This suggests afunctional division of the CaM kinase II molecule into homologous 
and variable domains. The homologous domains are highly conserved. Therefore, it might be the case that the constitution of the variable domains 
is more significant for a certain isoform than its belonging to one of the 4 subtypes a to 6. 
Calmodulin; Protein kinase; Isoform 
1. INTRODUCTION 
Calcium/calmodulin dependent protein kinase II 
(CaM kinase II) was originally described in rat brain 
tissue. Its complex autoregulation and its broad sub- 
strate range make it a candidate for an important regu- 
lator of intracellular signal transmission [1,2]. Impor- 
tant functions of CaM kinase II include the control of 
neurotrans~tter elease [3] and the mediation of stimu- 
lus induced gene expression [4]. 
From rat brain, five different subtypes were identified 
and cloned, termed ~1, ,6, /I’, y and 6 [5]. Subtype /3’ is 
probably a splicing variant of subtype/I [6]. CaM kinase 
II-like enzyme activities were also found in non-neu- 
ronal tissues [l]. In our previous work we described 
such an enzyme activity in the insulin secreting cell line 
RINmSF [7]. 
Northern blot analysis and PCR amplification of 
cDNA revealed that subtypes y and 6, but not a and 8, 
were present in non-neuronal tissues (ref. 5 and our 
unpublished observations). The calculated molecular 
weights of subtypes y and 6 are 59.0 kDa and 60.1 kDa, 
respectively. On the other hand, CaM kinase II type 
enzymes that were purified from several tissues except 
brain tissue often displayed molecular masses much 
smaller than these values (for example, 50 kDa in intes- 
tinal brush border, [S], and 51 kDa in rat pancreas [9]. 
This suggests that there could be further subtypes of 
CaM kinase II or, alternatively, splicing variants of the 
established isoforms. Nghiem et al. [lo] recently de- 
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scribed two putative splicing variants of human CaM 
kinase II y. We searched for variants of subtype 8. 
2. MATERIALS AND METHODS 
Total RNA was extracted from rat brain and RINmSF rat insuli- 
noma cells by the guanidinium isocyanate method [ 111. For reverse 
transcription, M-MLV reverse transcriptase from Gibco was used. 
The reaction buffer was also supplied by G&co. 
3 pairs of PCR primers were used to amplify the whole coding 
region of CaM kinase II 6 cDNA. The first upstream primer (se- 
quence, S-GGA GGA CGA GGA AGA AGG AT) started at base 
position -200 (base position 1, start of translation). The first down- 
stream primer (sequence, S-CAC CAG CAA GAT GTA GAG GA) 
started at base position 627 of the complementary strand. The next 
primer pair started at base position 502 and 1,417, respectively. Its 
sequence was S-CAG CAG GCG TGG ‘FTT GGT TT (upstream) 
and 5’-CCA TGT ACT GTG TGA GCC GA (downstream). The third 
primer pair started at base position 917 and 1,647, respectively. Its 
sequence was S-CAA CTA TGC TGG CTA CGA GA (upstream) 
and S-GAC GTG GCA CTG TTG ACA AT (do~stream). The 
PCR conditions were as follows: denatumtion at 95°C for 50 s; anneal- 
ing at 5X for the first primer pair and at 57°C for the other pairs 
for 2 min 30 s; elongation at 72°C for 5 min. Taq polymerase and 
reaction buffer were from Perkin Elmer or from Boehringer 
Mannheim. The concentration of MgCl, was adjusted to 1.5 mM for 
the left primer pair and to 3.5 mM for the other primer pairs. 
The amplificates were blunt-end ligated into the plasmid pBluescript 
from Stratagene or, alternatively, cloned into the plasmid pAMP 
(CloneAmp System from Gibco) according to manufacturer’s instruc- 
tions. Nucleotide sequencing was performed by the dideoxynucleotide 
chain termination method [12] using Sequenase 2.0 kit from USB. 
3. RESULTS AND DISCUSSION 
We amplified the coding region of CaM kinase II 6 
cDNA from RINmSF rat insulinoma cells and from rat 
brain using 3 pairs of PCR primers to obtain 3 overlap- 
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Fig. 1. Nucleotide sequence alignment of delta isoforms covering the potential deletion sites. Nucleotides are numbered beginning with the first 
nucleotide of the translation initiation codon. PCR primers are indicated by underlining. Gaps are indicated by dashes. 
ping fragments (see section 2 and Fig. 3). Within the 
coding region of CaM kinase II S cDNA, we detected 
2 distinct sites of possible deletions (Fig. 1, Fig. 3). 
These sites will be referred to as variable delta-domain 
#I and #2, respectively. Variable domain #l was 102 
bases long, coded for 34 amino acids, and spanned base 
positions 98551,086. This domain could be completely 
deleted, or, alternatively, only the right part of the do- 
main could be absent. This part was 42 bases or 14 
amino acids in length and spanned base positions 
1,045-l ,086. 
Variable delta-domain #2 spanned base positions 
15361,624. This domain was 89 bases in length and 
included the stop codon of subtype 6. Deletion of do- 
main #2 led to a shift of the reading frame for mRNA 
translation. By this means, a new stop codon (TAA) 
appeared i~ediately behind the deletion (Fig. 2). The 
result was a protein which lacked 21 amino acids at the 
316 
C-terminus of CaM kinase II 6. Simultaneously, L~s”~, 
which is located immediately in front of the deleted 
region, changed to Asn. The tail of 21 amino acids 
which constitutes the variable delta-domain #2 is not 
present in the subtypes a to y. 
The potential deletions described above make, by 
combination, 6 different variants of CaM kinase II S 
possible. Indeed, all these isoforms could be detected in 
rat tissues. The variants will be referred to as follows: 
The originally described subtype S will be termed 6, for 
clarity. 
In S,, variable domain #1 is deleted completely. 
In S,, variable domain #2 is deleted completely. 
In S,, both variable domains are completely deleted. 
In &,, the right part variable domain #l (base positions 
1,045-l ,086) is deleted. 
In S,, the right part variable domain #l (base positions 
1,045-1,086) is deleted as well as variable domain #2. 
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Cys Ile Pro Asn Gly Lys Glu Asn Phe Ser 
TGT ATT CCA AAT GGG AAA GAA AAC TTC TCA 
63 511 Ile Asn . . . . . . . . . . . . 
1531 ATC AA- ___ ___ --- --- --- --_ --- -a- ___ ___ ___ ___ 
61 525 Gly Gly Thr Ser Leu Trp Gln Asn Ile *** 
1573 GGA GGC ACC TCT TTG TGG CAA AAC ATC TGA AAA CCA TTC ACA 
63 . . . . 
___ --- ___ ___ 
. . . . . . . . . . 
___ ___ ___ ___ ___ --_ --_ ___ ___ ___ 
1615 TTT GGG TCT TCT AAT TGT . . . 
63 . . 1536 ,:_ ___ ___ 
*** 
-CTT TGT . . . 
Fig. 2. Illustration of the C-terminal deletion which includes the stop codon of subtype 6,. Nucleotide sequences and deduced amino acid sequences 
are shown for subtype S,, which possesses no deletion, and for subtype 6, in which variable domain #2 (see text) is deleted. 3 asterisks mark a 
stop codon. The new stopcodon in 6, resulting from a frame-shift is indicated by underlining. 
Subtypes &, &, S, were amplified and sequenced from 
rat brain, subtypes a2 and S, were amplified and se- 
quenced from RINm5F rat insulinoma cells. 
All isoforms of rat CaM kinase II which have been 
identified (including the 2 variants of human CaM ki- 
nase II y described recently [lo]) show a high overall 
homology to each other. Three areas of low homology 
are apparent [5]. The variable domains #l and #2 of the 
delta subtypes exactly match 2 of these areas of low 
homology (Fig. 4). In subtypes /I and y there is another 
area (#3) of low homology which is located N-terminal 
with respect to the variable delta domains focussed 
upon. This area is deleted in all delta isoforms. Note 
that the ‘variable domain’ defined by Nghiem et al. [lo] 
is composed of low homology area #3, variable domain 
#l and a short stretch of high conservation lying be- 
tween these variable areas. Interestingly, the 15 amino 
1 985 1086 1536 1624 
acid deletion which discriminates the subtypes j? and j?’ 
is homologous to the 14 amino acid deletion which we 
detected in the isoforms S, and 6,. 
The variable delta-domain #l is located between the 
regulation and the association domain of CaM kinase 
II. The variable domain #2 is placed behind the associ- 
ation domain at the C-terminus of the protein. These 
locations suggest an involvement of the variable do- 
mains in regulatory events as well as in the association 
behavior of CaM kinase II towards other proteins. If so, 
the conserved regions (including the kinase domain and 
the calmodulin binding site) would serve to recognize 
the calcium signal and to perform phosphorylation 
whereas the variable regions would direct the signal to 
its destination. The different isoforms could then be 
responsible for different and compartmentalized actions 
of calcium within the cell. 
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Fig. 3. Schematic view of CaM kinase II 6 mRNA. The coding region is indicated by a box. The areas of potential deletion are shaded (left, variable 
domain #l; right, variable domain #2). Note that region #l can be completely deleted or, alternatively, only in the right part (nucleotide positions 
1,045 to 1,086, dark shading). The numbers refer to nucleotide base positions. The positions of the PCR amplificates are indicated by horizontal 
lines. 
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KSGGNKKNDG_“K______________-__-_____________________ESSESTNTT 
KSLLNKKADG-VKPQTNSTKNSSAITSPKGSLPPAALEPQTTVIHNPVDGIKESSDSTNTT 
KSLLNKKADG-VKPQTNSTKNSSAITSPKGSLPPAAL----------------ESSDSTNTT 
KSLLNKKSDGGVK----KRKSSSSVH--------- LMEPQTTVVNNATDGIKGSTESCNTT 
KSLLNKKSDGGVKPQSNN-KNSLVSPAQEPAPLQTAMEPQNATDGIKGSTESCNTT 
KSLLNKKSDGGVK------------------------EPQTT~NATDGIKGSTESCNTT 
KSLL-KKPDG-VK--INNKAN--WTSPKENIPTPALEPQTTVIHNP-DGNKESTESSNTT 
KSLL~KKPDG~VK~~~~~~~~~~~~~~~~~~-~~--~---~~~~~~~~~~~~ESTESSNTT 
KSLL-KKPDG-VK--INNKAN--WTSPKENIPTPALEPQTTVIHNP-DGNKESTESSNTT 
KSLL_KKPDG~VK~~~~~---~------~__~~~~~~~~~~~~~~~~~~~~~ESTESSNTT 
KSLL-KKPDG-VK--INNKAN--WTSPKENIPTPAL---------------ESTESSNTT 
KSLL-KKPDG-VK--INNKAN--WTSPKENIPTPAL---------------ESTESSNTT 
Fig. 4. Alignment of the deduced amino acid sequences of all identified CaM kinase II isoforms. The alignment only surrounds the potential deletion 
sites. Amino acids are represented by single letter code. Gaps are indicated by dashes. Note that the deletion sites in subtype S match the regions 
of low homology between the subtypes a to 6 (underlined). A, alignment surrounding variable domain #l (see text). B, alignment surrounding 
variable domain #2 (see text). 
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